Citations

Showing 10 of 108119 citations.

Epidemiology of Herpes Zoster in Children and Adolescents: A Population-Based Study
Guess, H. A., Broughton, Daniel D., Melton, L. Joseph, Kurland, L. T.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 76 | Issue: 4 | Pages: 512-517

10.1542/peds.76.4.512 Get It

Medical records were reviewed for all 173 cases of herpes zoster diagnosed among residents of Rochester, Minnesota, less than 20 years of age during the period 1960 through 1981. The incidence of zoster increased with age from 20 cases per 100,000 person-years in those residents less than five years of age to 63 cases per 100,000 person-years in those aged 15 to 19. Morbidity was less than has been described in adults, as only two patients required hospitalization and no postherpetic neuralgia or other late complications were diagnosed. The single case of subsequent cancer found in 1,288 person-years of follow-up was not significantly different from the number expected based on cancer incidence in the general Rochester population. The incidence of childhood zoster in patients with acute lymphocytic leukemia was 122 times higher than in children without an underlying malignancy. Chickenpox in the first year of life was found to be a risk factor for childhood zoster, with a relative risk between 2.8 and 20.9. Neither chickenpox in the second year of life nor recent vaccinations were found to be risk factors for childhood zoster.
`Failure to Thrive' or the Failure to Define
Stickler, Gunnar B.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 74 | Issue: 4 | Pages: 559-559

10.1542/peds.74.4.559 Get It

Smith and Berenberg wrote a commentary, "The Concept of Failure to Thrive," in these pages in 1970.1 After recounting the history of the term, they added: "We hope that as a label it will not become indistinct or obscured by uncertainty as to its past, current, or future diagnostic implications." Their warning was appropriate, but numerous authors have failed to accept their concern. Failure to thrive is assigned as a diagnosis to many children. To some physicians, it means that a child fails to gain weight; others intend it to include failure to grow. It is widely assumed that a failure to gain entails inevitably a failure to grow.
Intellectual Malnutrition: American Schools and the Pediatrician's Duty
Stickler, Gunnar B.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 74 | Issue: 4 | Pages: 557-557

10.1542/peds.74.4.557 Get It

"U.S. 6th-graders do poorly on math, science tests." That was the sober, accurate headline given by the Minneapolis Star and Tribune to an Associated Press story on Dec 12, 1983. The judgment "poorly" was based on comparison with students in seven other countries. Prominent American scientists and academicians—Glenn Seaborg, Stephen Willoughby, Joseph Stoltman, and Gilbert White—developed the tests on mathematics, science, and geography. They were given to sixth-grade students in Australia, Canada, England, France, Japan, Sweden, Switzerland, and the United States in schools selected to represent the average in their countries. In geography, the Swedes were first with 54.1 and Americans were fourth with 45.8.
The Attack on the Tympanic Membrane
Stickler, Gunnar B.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 74 | Issue: 2 | Pages: 291-292

10.1542/peds.74.2.291 Get It

Fluid in the ear, glue ear, and conductive hearing loss have replaced the "infected, large, or hypertrophied tonsils" and "enlarged adenoids" as a major concern of primary physicians caring for children and the special domain of ear, nose, and throat physicians. Having myringotomy tubes put into the ears has become a favorite topic of discussion for parents marveling at the positive effects. Indeed, these devices must be something of a fashion or status symbol, because it is estimated that tubes of various configurations and materials are placed into the tympanic membrane of at least 1 million children per year in this country.
Letter to the Editor
Robinette, Martin S.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 94 | Issue: 6 | Pages: 952-954

10.1542/peds.94.6.952 Get It

The importance of early identification of hearing loss is summarized in the report issued by the United States (US) Department of Health and Human Services,1 entitled "Healthy People 2000." The goal is to reduce the average age at which children with significant hearing impairment are identified to no more than 12 months. The report states: The future of a child born with significant hearing impairment depends to a very large degree on early identification (ie, audiological diagnosis before 12 months of age) followed by immediate and appropriate intervention.
Barriers to Adult Cochlear Implant Care in the United States: An Analysis of Health Care Delivery
Nassiri, Ashley M. , Marinelli, John P. , Sorkin, Donna L., Carlson, Matthew L.

Mayo Clinic

Seminars in Hearing | December 9, 2021 | Volume: 42 | Issue: 04 | Pages: 311-320

10.1055/s-0041-1739281 | PMID 34912159 Get It

AbstractPersistent underutilization of cochlear implants (CIs) in the United States is in part a reflection of a lack of hearing health knowledge and the complexities of care delivery in the treatment of sensorineural hearing loss. An evaluation of the patient experience through the CI health care delivery process systematically exposes barriers that must be overcome to undergo treatment for moderate-to-severe hearing loss. This review analyzes patient-facing obstacles including diagnosis of hearing loss, CI candidate identification and referral to surgeon, CI evaluation and candidacy criteria interpretation, and lastly CI surgery and rehabilitation. Pervasive throughout the process are several themes which demand attention in addressing inequities in hearing health disparities in the United States.
Tilt-Table Testing and Oral Metoprolol Therapy in Young Patients With Unexplained Syncope
MacLellan-Tobert, Susan C., Porter, Co-burn J., O’Marcaigh, Aengus

Mayo Clinic

Pediatrics | December 9, 2021 | Volume: 93 | Issue: 2 | Pages: 278-283

10.1542/peds.93.2.278 Get It

Objective. Tilt-table testing is useful for investigating unexplained syncope in pediatric patients. No data are available on the use of intravenous metoprolol during testing to identify children who might respond to subsequent oral β-adrenergic blockade or on the efficacy and safety of such oral therapy. Design. To provide these data, we obtained follow-up information on 27 consecutive pediatric patients who had tilt-table testing for unexplained syncope. Results. Nineteen patients (70%) had positive test results with or without isoproterenol infusion. All these patients had negative test results after intravenous infusion of metoprolol and subsequently were treated with oral metoprolol. Taking oral metoprolol therapy alone, 9 (47%) of the 19 patients were asymptomatic, 8 (42%) reported a decreased frequency of syncopal episodes, and 2 (11%) had unchanged or more frequent episodes. The mean dosage of metoprolol required to prevent symptoms was 1.5 mg/kg per day. Mild side effects were reported by 6 (32%) of the 19 patients. Six patients (32%) required additional medications. Conclusions. We conclude that metoprolol is safe and effective for the treatment of most cases of neurocardiogenic syncope in children and that this response cannot be predicted accurately by the use of intravenous metoprolol during testing.
Heavy Ion Minibeam Therapy: Side Effects in Normal Brain
Eley, John G. , Haga, Catherine , Lazenby, Ellis M., Raver, Charles , Rusek, A., Dilmanian, F. Avraham, Waddell, Jaylyn , Keller, Asaf , Krishnan, Sunil

Mayo Clinic

Cancers | December 9, 2021 | Volume: 13 | Issue: 24 | Pages: 6207

10.3390/cancers13246207 | PMID 34944825 Get It

The purpose of this work was to investigate whether minibeam therapy with heavy ions might offer improvements of the therapeutic ratio for the treatment of human brain cancers. To assess neurotoxicity, we irradiated normal juvenile rats using 120 MeV lithium-7 ions at an absorbed integral dose of 20 Gy. Beams were configured either as a solid parallel circular beam or as an array of planar parallel minibeams having 300-micron width and 1-mm center-to-center spacing within a circular array. We followed animals for 6 months after treatment and utilized behavioral testing and immunohistochemical studies to investigate the resulting cognitive impairment and chronic pathologic changes. We found both solid-beam therapy and minibeam therapy to result in cognitive impairment compared with sham controls, with no apparent reduction in neurotoxicity using heavy ion minibeams instead of solid beams under the conditions of this study.
PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers
Saric, Petar , Young, Kathleen A. , Rodriguez‐Porcel, Martin , Chareonthaitawee, Panithaya

Mayo Clinic

Pharmaceuticals | December 9, 2021 | Volume: 14 | Issue: 12 | Pages: 1286

10.3390/ph14121286 | PMID 34959686 Get It

Sarcoidosis is a multi-system inflammatory disease characterized by the development of inflammation and noncaseating granulomas that can involve nearly every organ system, with a predilection for the pulmonary system. Cardiac involvement of sarcoidosis (CS) occurs in up to 70% of cases, and accounts for a significant share of sarcoid-related mortality. The clinical presentation of CS can range from absence of symptoms to conduction abnormalities, heart failure, arrhythmias, valvular disease, and sudden cardiac death. Given the significant morbidity and mortality associated with CS, timely diagnosis is important. Traditional imaging modalities and histologic evaluation by endomyocardial biopsy often provide a low diagnostic yield. Cardiac positron emission tomography (PET) has emerged as a leading advanced imaging modality for the diagnosis and management of CS. This review article will summarize several aspects of the current use of PET in CS, including indications for use, patient preparation, image acquisition and interpretation, diagnostic and prognostic performance, and evaluation of treatment response. Additionally, this review will discuss novel PET radiotracers currently under study or of potential interest in CS.
Relationships between cerebrovascular reactivity, visual-evoked functional activity, and resting-state functional connectivity in the visual cortex and basal forebrain in glaucoma
Chan, Russell W. , Trivedi, Vivek, Murphy, Matthew C. , Wollstein, Gadi , Schuman, Joel S. , Schuman, Joel S , Bang, Ji Won , Liu, Peiying , Chan, Kevin C.

Mayo Clinic

2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) | December 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: 4037-4040

10.1109/embc46164.2021.9630904 | PMID 34892116 Get It